Resource Center
Join us for an insightful discussion on TTV viral load monitoring as a promising tool in clinical diagnostics, providing critical information for managing patient health, particularly in those with compromised immune systems, including solid organ transplant recipients. Don't miss this opportunity to delve into cutting-edge insights and optimize treatment outcomes. Includes a Q&A Session.

This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.